Enhancing Respiratory Medication Adherence: The Role of Health Care Professionals and Cost-Effectiveness Considerations

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 5, 2016, Pages 835-846

  van Boven, Job F M ^a,b   Ryan, Dermot ^c   Eakin, Michelle N ^d   Canonica, Giorgio W ^e   Barot, Aji ^f   Foster, Juliet M ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GENOA   (Italy)

^f Patient Connect Service   (United Kingdom)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; COPD; cost effectiveness; Health care professionals; Implementation; Initiation; Medication adherence interventions; Persistence

Indexed keywords

CORTICOSTEROID; RESPIRATORY TRACT AGENT;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNICATION SKILL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG USE; EMPOWERMENT; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HOLISTIC CARE; HUMAN; INDIVIDUALIZATION; INHALER; INTERPERSONAL COMMUNICATION; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PHARMACIST ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; SELF CARE; SHARED DECISION MAKING; SMOKING; SOCIAL SUPPORT; UNSPECIFIED SIDE EFFECT; COST BENEFIT ANALYSIS; ECONOMICS; PRIMARY HEALTH CARE; PROFESSIONAL STANDARD; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ASTHMA; COST-BENEFIT ANALYSIS; HEALTH PERSONNEL; HUMANS; MEDICATION ADHERENCE; PRIMARY HEALTH CARE; PROFESSIONAL ROLE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYSTEM AGENTS;

EID: 84992047046     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.03.007     Document Type: Article

References (96)

1. 1 Feehan, M., Ranker, L., Durante, R., Cooper, D.K., Jones, G.J., Young, D.C., et al. Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain. J Clin Pharm Ther 40 (2015), 590–593.
2. 2 Braido, F., Baiardini, I., Blasi, F., Pawankar, R., Canonica, G.W., Adherence to asthma treatments: ‘we know, we intend, we advocate’. Curr Opin Allergy Clin Immunol 15 (2015), 49–55.
3. 3 Bourbeau, J., Bartlett, S.J., Patient adherence in COPD. Thorax 63 (2008), 831–838.
4. 4 Dima, A.L., Hernandez, G., Cunillera, O., Ferrer, M., de Bruin, M., ASTRO-LAB Group. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J 45 (2015), 994–1018.
5. 5 George, J., Kong, D.C., Thoman, R., Stewart, K., Factors associated with medication nonadherence in patients with COPD. Chest 128 (2005), 3198–3204.
6. 6 Claxton, A.J., Cramer, J., Pierce, C., A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23 (2001), 1296–1310.
7. 7 Cooper, V., Metcalf, L., Versnel, J., Upton, J., Walker, S., Horne, R., Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Respir Med, 25, 2015, 15026.
8. 8 Restrepo, R.D., Alvarez, M.T., Wittnebel, L.D., Sorenson, H., Wettstein, R., Vines, D.L., et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 3 (2008), 371–384.
9. 9 van Boven, J.F., van Raaij, J.J., van der Galien, R., Postma, M.J., van der Molen, T., Dekhuijzen, P.N., et al. Impact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting beta(2)-agonists: a dispensing database analysis. NPJ Prim Care Respir Med, 24, 2014, 14069.
10. 10 Rutten-van Molken, M.P., Goossens, L.M., Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues. Pharmacoeconomics 30 (2012), 271–302.
11. 11 Dima, A.L., de Bruin, M., Van Ganse, E., ASTRO-LAB group. Mapping the asthma care process: implications for research and practice. J Allergy Clin Immunol Pract, 2016.
12. 12 Ryan, D., Murphy, A., Stallberg, B., Baxter, N., Heaney, L.G., ‘SIMPLES’: a structured primary care approach to adults with difficult asthma. Prim Care Respir J 22 (2013), 365–373.
13. 13 van der Palen, J., Klein, J.J., van Herwaarden, C.L., Zielhuis, G.A., Seydel, E.R., Multiple inhalers confuse asthma patients. Eur Respir J 14 (1999), 1034–1037.
14. 14 Fink, J.B., Rubin, B.K., Problems with inhaler use: a call for improved clinician and patient education. Respir Care 50 (2005), 1360–1374 discussion 1374-5.
15. 15 Levy, M.L., Hardwell, A., McKnight, E., Holmes, J., Asthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 22 (2013), 406–411.
16. 16 Thomas, M., Gruffydd-Jones, K., Stonham, C., Ward, S., Macfarlane, T.V., Assessing asthma control in routine clinical practice: use of the Royal College of Physicians ‘3 questions’. Prim Care Respir J 18 (2009), 83–88.
17. 17 Gamble, J., Stevenson, M., Heaney, L.G., A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med 105 (2011), 1308–1315.
18. 18 Royal College of General Practitioners. Patient centred care in the 21st century. 2014. Available from: http://www.rcgp.org.uk/policy/rcgp-policy-areas/∼/media/Files/Policy/A-Z-policy/RCGP-Inquiry-into-Patient-Centred-Care-in-the-21st-Century.ashx. Accessed March 11, 2016.
19. 19 Caress, A.L., Beaver, K., Luker, K., Campbell, M., Woodcock, A., Involvement in treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey. Thorax 60 (2005), 199–205.
20. 20 Plaza, V., Peiro, M., Torrejon, M., Fletcher, M., Lopez-Vina, A., Ignacio, J.M., et al. A repeated short educational intervention improves asthma control and quality of life. Eur Respir J 46 (2015), 1298–1307.
21. 21 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2015. Available from: http://www.goldcopd.org/. Accessed December 22, 2015.
22. 22 Suissa, S., Kezouh, A., Ernst, P., Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 123 (2010), 1001–1006.
23. 23 Suissa, S., Patenaude, V., Lapi, F., Ernst, P., Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax 68 (2013), 1029–1036.
24. 24 Foster, J.M., Jenkins, C.R., Toelle, B.G., Smith, L., Reddel, H.K., “It must be doing something”: COPD patients’ rationales for using combination ICS/LABA treatment. Am J Respir Crit Care Med, 257, 2015, A6175.
25. 25 Horne, R., Compliance, adherence, and concordance: implications for asthma treatment. Chest 130 (2006), 65S–72S.
26. 26 Moreau, A., Aroles, V., Souweine, G., Flori, M., Erpeldinger, S., Figon, S., et al. Patient versus general practitioner perception of problems with treatment adherence in type 2 diabetes: from adherence to concordance. Eur J Gen Pract 15 (2009), 147–153.
27. 27 Miravitlles, M., Ferrer, J., Baro, E., Lleonart, M., Galera, J., Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med 107 (2013), 1977–1985.
28. 28 Riekert, K.A., Butz, A.M., Eggleston, P.A., Huss, K., Winkelstein, M., Rand, C.S., Caregiver-physician medication concordance and undertreatment of asthma among inner-city children. Pediatrics 111 (2003), e214–e220.
29. 29 Partridge, M.R., Hill, S.R., Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group. Eur Respir J 16 (2000), 333–348.
30. 30 Moffat, M., Cleland, J., van der Molen, T., Price, D., Sub-optimal patient and physician communication in primary care consultations: its relation to severe and difficult asthma. Prim Care Respir J 15 (2006), 159–165.
31. 31 Makoul, G., Essential elements of communication in medical encounters: the Kalamazoo consensus statement. Acad Med 76 (2001), 390–393.
32. 32 Del Mar, C., Doust, J., Glasziou, P.P., Critical thinking: evidence, communication and decision making. 2006, BMJ Books, Oxford, United Kingdom, 12–26.
33. 33 Beck, R.S., Daughtridge, R., Sloane, P.D., Physician-patient communication in the primary care office: a systematic review. J Am Board Fam Pract 15 (2002), 25–38.
34. 34 Kemp, E.C., Floyd, M.R., McCord-Duncan, E., Lang, F., Patients prefer the method of “tell back-collaborative inquiry” to assess understanding of medical information. J Am Board Fam Med 21 (2008), 24–30.
35. 35 Global Initiative for Asthma. Global strategy for asthma management and prevention 2014. Available from: www.ginasthma.org. Accessed December 22, 2015.
36. 36 National Asthma Council Australia. Asthma adherence: a guide for health professionals 2005. Available from: http://www.nationalasthma.org.au/uploads/publication/asthma-adherence.pdf. Accessed December 19, 2015.
37. 37 Foster, J.M., Smith, L., Bosnic-Anticevich, S.Z., Usherwood, T., Sawyer, S.M., Rand, C.S., et al. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J 42 (2012), e136–e144.
38. 38 Foster, J.M., Smith, L., Usherwood, T., Sawyer, S.M., Reddel, H.K., General practitioner-delivered adherence counseling in asthma: feasibility and usefulness of skills, training and support tools. J Asthma 53 (2016), 311–320.
39. 39 Smith, L., Alles, C., Lemay, K., Reddel, H., Saini, B., Bosnic-Anticevich, S., et al. The contribution of goal specificity to goal achievement in collaborative goal setting for the management of asthma. Res Soc Adm Pharm 9 (2013), 918–929.
40. 40 Clark, N.M., Cabana, M.D., Nan, B., Gong, Z.M., Slish, K.K., Birk, N.A., et al. The clinician-patient partnership paradigm: outcomes associated with physician communication behavior. Clin Pediatr (Phila) 47 (2008), 49–57.
41. 41 Williams, S., Weinman, J., Dale, J., Newman, S., Patient expectations: what do primary care patients want from the GP and how far does meeting expectations affect patient satisfaction?. Fam Pract 12 (1995), 193–201.
42. 42 Schillinger, D., Piette, J., Grumbach, K., Wang, F., Wilson, C., Daher, C., et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 163 (2003), 83–90.
43. 43 Charles, C., Gafni, A., Whelan, T., Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 44 (1997), 681–692.
44. 44 Frosch, D.L., Kaplan, R.M., Shared decision making in clinical medicine: past research and future directions. Am J Prev Med 17 (1999), 285–294.
45. 45 Wilson, S.R., Strub, P., Buist, A.S., Knowles, S.B., Lavori, P.W., Lapidus, J., et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 181 (2010), 566–577.
46. 46 Schneider, A., Wensing, M., Quinzler, R., Bieber, C., Szecsenyi, J., Higher preference for participation in treatment decisions is associated with lower medication adherence in asthma patients. Pat Educ Couns 67 (2007), 57–62.
47. 47 Yoos, H.L., Kitzman, H., McMullen, A., Sidora, K., Symptom perception in childhood asthma: how accurate are children and their parents?. J Asthma 40 (2003), 27–39.
48. 48 Drotar, D., Physician behavior in the care of pediatric chronic illness: association with health outcomes and treatment adherence. J Dev Behav Pediatr 30 (2009), 246–254.
49. 49 Butz, A.M., Walker, J.M., Pulsifer, M., Winkelstein, M., Shared decision making in school age children with asthma. Pediatr Nurs 33 (2007), 111–116.
50. 50 Price, D., Fletcher, M., van der Molen, T., Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med, 24, 2014, 14009.
51. 51 Tommelein, E., Mehuys, E., Van Hees, T., Adriaens, E., Van Bortel, L., Christiaens, T., et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol 77 (2014), 756–766.
52. 52 NHS England. Improving health and patient care through community pharmacy–a call to action 2013. Available from: https://www.england.nhs.uk/ourwork/qual-clin-lead/calltoaction/pharm-cta. Accessed December 22, 2015.
53. 53 Pharmaceutical Services Negotiating Committee. Responding to the National Review of Asthma Deaths (NRAD) 2014. Available from: http://psnc.org.uk/wp-content/uploads/2014/07/PSNC-Response-to-NRAD-June-2014.pdf. Accessed December 10, 2015.
54. 54 Gallup. Available from: http://www.gallup.com/poll/159035/congress-retains-low-honesty-rating.aspx. Accessed December 11, 2015.
55. 55 van Boven, J.F., Stuurman-Bieze, A.G., Hiddink, E.G., Postma, M.J., Vegter, S., Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm 20 (2014), 786–792.
56. 56 Lieu, T.A., Quesenberry, C.P., Sorel, M.E., Mendoza, G.R., Leong, A.B., Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med 157 (1998), 1173–1180.
57. 57 van Boven, J.F., Hiddink, E.G., Stuurman-Bieze, A.G., Schuiling-Veninga, C.C., Postma, M.J., Vegter, S., The pharmacists’ potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. Int J Clin Pharm 35 (2013), 1075–1082.
58. 58 Elliott, R.A., Boyd, M.J., Salema, N.E., Davies, J., Barber, N., Mehta, R.L., et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service [e-pub ahead of print]. BMJ Qual Saf, 2015, 10.1136/bmjqs-2015-004400.
59. 59 Latif, A., Waring, J., Watmough, D., Barber, N., Chuter, A., Davies, J., et al. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy. [e-pub ahead of print] Res Soc Adm Pharm, 2015, 10.1016/j.sapharm.2015.12.007.
60. 60 Cabana, M.D., Slish, K.K., Evans, D., Mellins, R.B., Brown, R.W., Lin, X., et al. Impact of physician asthma care education on patient outcomes. Pediatrics 117 (2006), 2149–2157.
61. 61 Butz, A.M., Walker, J., Land, C.L., Vibbert, C., Winkelstein, M., Improving asthma communication in high-risk children. J Asthma 44 (2007), 739–745.
62. 62 Eakin, M.N., Rand, C.S., Bilderback, A., Bollinger, M.E., Butz, A., Kandasamy, V., et al. Asthma in Head Start children: effects of the Breathmobile program and family communication on asthma outcomes. J Allergy Clin Immunol 129 (2012), 664–670.
63. 63 Leiva-Fernandez, J., Leiva-Fernandez, F., Garcia-Ruiz, A., Prados-Torres, D., Barnestein-Fonseca, P., Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial. BMC Pulm Med, 14, 2014, 70.
64. 64 Onyirimba, F., Apter, A., Reisine, S., Litt, M., McCusker, C., Connors, M., et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol 90 (2003), 411–415.
65. 65 Reddel, H.K., Toelle, B.G., Marks, G.B., Ware, S.I., Jenkins, C.R., Woolcock, A.J., Analysis of adherence to peak flow monitoring when recording of data is electronic. BMJ 324 (2002), 146–147.
66. 66 Williams, L.K., Peterson, E.L., Wells, K., Campbell, J., Wang, M., Chowdhry, V.K., et al. A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol 126 (2010), 225–231 e1-4.
67. 67 Foster, J.M., Usherwood, T., Smith, L., Sawyer, S.M., Xuan, W., Rand, C.S., et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol 134 (2014), 1260–1268.e3.
68. 68 Nides, M.A., Tashkin, D.P., Simmons, M.S., Wise, R.A., Li, V.C., Rand, C.S., Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 104 (1993), 501–507.
69. 69 Simmons, M.S., Nides, M.A., Rand, C.S., Wise, R.A., Tashkin, D.P., Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 109 (1996), 963–968.
70. 70 Haynes, R.B., Taylor, D.W., Sackett, D.L., Compliance in health care. 1979, Johns Hopkins University Press, Baltimore, Md.
71. 71 Eaddy, M.T., Cook, C.L., O'Day, K., Burch, S.P., Cantrell, C.R., How patient cost-sharing trends affect adherence and outcomes: a literature review. P T 37 (2012), 45–55.
72. 72 Elliott, R.A., Barber, N., Horne, R., Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 39 (2005), 508–515.
73. 73 Chatkin, J.M., Blanco, D.C., Scaglia, N., Wagner, M.B., Fritscher, C.C., Impact of a low-cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. J Asthma 43 (2006), 263–266.
74. 74 Suijkerbuijk, A.W., de Wit, G.A., Wijga, A.H., Heijmans, M., Hoogendoorn, M., Rutten-van Molken, M., et al. Societal costs of asthma, COPD and respiratory allergy. Ned Tijdschr Geneeskd, 157, 2013, A6562.
75. 75 van Boven, J.F., Chavannes, N.H., van der Molen, T., Rutten-van Molken, M.P., Postma, M.J., Vegter, S., Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med 108 (2014), 103–113.
76. 76 Vestbo, J., Anderson, J.A., Calverley, P.M., Celli, B., Ferguson, G.T., Jenkins, C., et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 64 (2009), 939–943.
77. 77 Makela, M.J., Backer, V., Hedegaard, M., Larsson, K., Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 107 (2013), 1481–1490.
78. 78 van Boven, J.F., Tommelein, E., Boussery, K., Mehuys, E., Vegter, S., Brusselle, G.G., et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res, 15, 2014, 66.
79. 79 Wright, D., Twigg, M., Barton, G., Thornley, T., Kerr, C., An evaluation of a multi-site community pharmacy-based chronic obstructive pulmonary disease support service. Int J Pharm Pract 23 (2015), 36–43.
80. 80 Williams, L.K., Pladevall, M., Xi, H., Peterson, E.L., Joseph, C., Lafata, J.E., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114 (2004), 1288–1293.
81. 81 Herndon, J.B., Mattke, S., Evans Cuellar, A., Hong, S.Y., Shenkman, E.A., Anti-inflammatory medication adherence, healthcare utilization and expenditures among Medicaid and children's health insurance program enrollees with asthma. Pharmacoeconomics 30 (2012), 397–412.
82. 82 Sadatsafavi, M., Chen, W., Tavakoli, H., Rolf, J.D., Rousseau, R., FitzGerald, J.M., Economic Burden of Asthma Study Group. Saving in medical costs by achieving guideline-based asthma symptom control: a population-based study. Allergy 71 (2016), 371–377.
83. 83 Zafari, Z., Lynd, L.D., FitzGerald, J.M., Sadatsafavi, M., Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study. J Allergy Clin Immunol 134 (2014), 908–915.e3.
84. 84 Cruz, A.A., Souza-Machado, A., Franco, R., Souza-Machado, C., Ponte, E.V., Moura Santos, P., et al. The impact of a program for control of asthma in a low-income setting. World Allergy Organ J 3 (2010), 167–174.
85. 85 van Boven, J.F., Stuurman-Bieze, A.G., Hiddink, E.G., Postma, M.J., Effects of targeting disease and medication management interventions towards patients with COPD. Curr Med Res Opin 32 (2016), 229–239.
86. 86 Williams, L.K., Peterson, E.L., Wells, K., Ahmedani, B.K., Kumar, R., Burchard, E.G., et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 128 (2011), 1185–1191.e2.
87. 87 Taitel, M.S., Sanchez, R.J., Fensterheim, L.E., Mardekian, J., Cannon, A.E., Rough, T.B., et al. Pharmacist-delivered interventions impact on target and non-target chronic medication adherence. Am J Pharm Benefits 6 (2014), 115–124.
88. 88 Sullivan, P.W., Ghushchyan, V.H., Slejko, J.F., Belozeroff, V., Globe, D.R., Lin, S.L., The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 127 (2011), 363–369.e1-3.
89. 89 van Boven, J.F., Vegter, S., van der Molen, T., Postma, M.J., COPD in the working age population: the economic impact on both patients and government. COPD 10 (2013), 629–639.
90. 90 Rabe, K.F., Fabbri, L.M., Vogelmeier, C., Kogler, H., Schmidt, H., Beeh, K.M., et al. Seasonal distribution of COPD exacerbations in the prevention of exacerbations with tiotropium in COPD trial. Chest 143 (2013), 711–719.
91. 91 Jenkins, C.R., Celli, B., Anderson, J.A., Ferguson, G.T., Jones, P.W., Vestbo, J., et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 39 (2012), 38–45.
92. 92 Wark, P.A., Gibson, P.G., Asthma exacerbations. 3: pathogenesis. Thorax 61 (2006), 909–915.
93. 93 Chan, A.H., Harrison, J., Black, P.N., Mitchell, E.A., Foster, J.M., Using electronic monitoring devices to measure inhaler adherence: a practical guide for clinicians. J Allergy Clin Immunol Pract 3 (2015), 335–349.e1-5.
94. 94 D'Arcy, S., MacHale, E., Seheult, J., Holmes, M.S., Hughes, C., Sulaiman, I., et al. A method to assess adherence in inhaler use through analysis of acoustic recordings of inhaler events. PLoS One, 9, 2014, e98701.
95. 95 van Boven, J.F., Trappenburg, J.C., van der Molen, T., Chavannes, N.H., Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med, 25, 2015, 15046.
96. 96 Pinnock, H., Ostrem, A., Rodriguez, M.R., Ryan, D., Stallberg, B., Thomas, M., et al. Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise. Prim Care Respir J 21 (2012), 19–27.